BIOVAXYS PARTNER SPAYVAC FOR WILDLIFE, INC., SCALES-UP VACCINE PRODUCTION CAPACITY
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac for Wildlife, Inc. are pleased to ...
BioVaxys Technology Corp.: BIOVAXYS PARTNER SPAYVAC FOR WILDLIFE, INC., SCALES-UP VACCINE PRODUCTION CAPACITY
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac for Wildlife, Inc. are pleased to ...
The Week3h
Neoantigen DNA vaccine shows promising results against triple-negative breast cancer in initial study
Treatment with personalised neoantigen DNA vaccines is feasible, says a clinical-trial-based study published in Genome ...
Investing1d
Moderna stock climbs as HSBC upgrades to Buy on underestimated pipeline potential
Moderna stock has been on a downward trajectory over the past few months, with HSBC analysts attributing the weakness to ...
News Medical2d
Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients
A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...
New therapeutic vaccine gives hope against an aggressive breast cancer
An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, ...
GoodNewsNetwork4d
Hope for Patients with Aggressive Breast Cancer: Vaccine Trial Results in 88% Survival Rate After 3 Years
After surgery, the team analyzed and compared the tumor tissue with the healthy tissue of the same patient to find unique ...
Too Old to Operate5d
Neoantigen DNA Vaccines Safe, Induce Response in Triple-Negative Breast Cancer
Neoantigen DNA vaccines are safe and capable of inducing neoantigen-specific immune responses in patients with ...
Medindia5d
Neoantigen DNA Vaccine for Triple-Negative Breast Cancer Shows High Survival Rates
A clinical trial at WashU Medicine shows promising results for a personalized vaccine designed to prevent recurrence in triple-negative breast cancer patients.
healthday5d
New Vaccine Shows Promise Against Aggressive Form of Breast Cancer
A new vaccine that targets an aggressive form of breast cancer is showing promising results in early trials.The vaccine – ...
Neoantigen DNA vaccine shows promise against aggressive breast cancer in clinical trial
A small clinical trial shows promising results for patients with triple-negative breast cancer who received an ...
talker on MSN5d
New vaccine shows promise in treating aggresive form of breast cancer
A trial of the vaccine showed it to be "well-tolerated" and to stimulate the immune system. The post New vaccine shows ...